Medic-ma 4 MK Spółka z Ograniczoną Odpowiedzialnością Spółka Komandytowa (KRS 0000597664, NIP 7952535350) is a Polish company, headquartered in Przemyśl, Podkarpackie voivodeship. Medic-ma 4 MK Spółka z Ograniczoną Odpowiedzialnością operates in: Other retail sale of new goods in specialised stores (PKD 47.78.Z). Industry: Retail trade. The company has been listed in the National Court Register since January 19, 2016. Medic-ma 4 MK Spółka z Ograniczoną Odpowiedzialnością's operations are currently suspended.
The company is currently suspended
Suspended since October 1, 2025
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Medic-ma 4 MK
Identity
- Name
- Medic-ma 4 MK Spółka z Ograniczoną Odpowiedzialnością Spółka Komandytowa
- Legal form
- SPÓŁKA KOMANDYTOWA
- Founded
- January 19, 2016
- Registry status as of
- December 4, 2025
- Latest entry
- October 21, 2025
- Founding act
- 18-01-2016 R.
Articles of association history (1)
- 18-01-2016 R.
Activities
Other activities
Address and contact
- Address
- UL. MARCINA BIELSKIEGO, 39, 37-700, PRZEMYŚL, POLSKA
- Voivodeship
- PODKARPACKIE
- District
- PRZEMYŚL
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Operational status - Medic-ma 4 MK
Founded
January 19, 2016
10 years in operation
Legal form
SPÓŁKA KOMANDYTOWA
Registry: RejP
Headquarters
PRZEMYŚL
PODKARPACKIE
Primary PKD
47.78.Z
Other retail sale of new goods in specialised stores
Shareholders
3
shareholders
Registry entries
24
latest: October 21, 2025
Risk signals
No KPI data - financial statements and valuation are unavailable for this company.
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Medic-ma 4 MK.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1m capex (+212%), a PLN 1.10 dividend three years running, Cydr Lubelski and Romanian Zarea as the premium engines
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8m of revenue and PLN 49.0m of net profit, while raising capex by 212% to PLN 48.1m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9m acquisition of a Romanian company. Despite the heavy investment cycle the board is keeping the PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7bn (+13% YoY), EBITDA of PLN 56m (+63%) and net profit of PLN 9.3m - a return to the black after a PLN 10m loss in 2024. Poland grew 31%, but CEE was under FX pressure (hryvnia -11% versus the zloty), and a weak Q4 (EBITDA -71% YoY) prompted the supervisory board to cut the 2026 EBITDA target from PLN 100m to PLN 90m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
